Massimo Bani
GlaxoSmithKline R&D
Verona, Italy
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 27, 2024
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: September 15, 2023
Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development.
Journal: The AAPS journal
Published: May 23, 2023
Evaluation and Application of a PET Tracer in Preclinical and Phase 1 Studies to Determine the Brain Biodistribution of Minzasolmin (UCB0599).
Journal: Molecular imaging and biology
Published: April 06, 2023
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: December 21, 2022
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 11, 2022
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation.
Journal: Clinical pharmacology and therapeutics
Published: October 27, 2020
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.
Journal: Clinical pharmacology and therapeutics
Published: April 09, 2019
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Journal: Journal of neurology
Published: February 28, 2019
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis.
Journal: Clinical and translational science
Published: April 13, 2017
Pharmacokinetics and metabolism of [14C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: August 05, 2016
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: June 10, 2016
Last Updated: 09/26/2026